The global medical devices CRO market should grow at a compound annual growth rate (CAGR) of 12.5%, reaching around $7.4 billion by 2018, according to a new study from GlobalData.
After establishing itself in southeastern Europe, Zeincro Group is ready to expand its reach on the Continent. The CRO announced that it has consolidated with another European CRO, Trial Masters, and in turn, is expanding its services to Hungary and Romania.
Thanks to an infusion of funding from a consortium of investors, CRO Inclinix has merged with integrated site network PMG Research.
Kansas City may be better known as one of America's barbecue destinations, but city is developing itself as a destination for outsourcing.
A Swiss pharmaceutical supplier has laid out more than $58 million in cash to acquire Allied Medical Products and get into the custom market for sterile filling services.
The NC facility ties into Catalent's plan to boost its offerings in areas like advanced blow-fill-seal aseptic delivery, delivery technologies and clinical trial supplies, among others.
With Medtox at its disposal, the diagnostic giant LabCorp hopes to strengthen its own work in providing toxicology services.
WuXi PharmaTech calls the 2011 incident the only known case of its kind in its 11-year history.
The partnership will have physician scientists from SCRI and Yale Cancer Center working together to develop protocols and priorities for clinical research protocols.
Global CMO Catalent Pharma Solutions will unload its U.S. commercial packaging operations and sell it to venture capital group Frazier Healthcare for an undisclosed fee, according to a Catalent release.
A newly formed contract research organization in California is hoping to set itself apart from competitors by focusing the bulk of its work on combating pediatric and orphan diseases.
The New Jersey CRO has teamed up with Bayer Healthcare in a deal that will see the two helping one another with R&D services.
As patents for key blockbuster drugs begin to expire and plant use begins to wane, experts are looking to Europe for a boom in contract manufacturing.
After almost three months of deliberations in U.S. Bankruptcy Court in Delaware, a bid has been accepted toward the sale of the North Carolina CRO.
The Motley Fool asks investors to pay close attention to Covance's free cash flow.
Based on the findings published in Quintiles' annual "New Health Report," payers want to get the ball rolling sooner to get drugs approved faster.
The acquisition will open the door for Vitrology to enter SGS' life sciences network that extends to more than 1,300 offices and laboratories around the world.
The Swedish CDMO says it will use the money to fund its growth.
David Simmons, a former Pfizer executive and general manager, will join Pharmaceutical Product Development as its new Chairman and CEO June 4.
PRA will open two new offices in Europe to support its growing staff and capabilities.